Breaking News

Pii Expands Formulation, Manufacturing Capabilities

Adds hot melt extrusion technology to portfolio

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Pharmaceutics International, Inc. (Pii) has added hot melt extrusion (HME) to its portfolio of formulation and process development solutions. The company has purchased a 16mm and an 18mm Leistritz twin screw extruders, an investment enabling Pii to carry out feasibility studies using just a few grams of API, to pilot scale cGMP productions for Phase I and II clinical trials using HME. “Pii’s investment in hot melt extrusion is part of the company’s goal of providing our client...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters